CEL-SCI Corporation Reports Second Quarter Fiscal 2024 Financial Results

CEL-SCI Corporation today reported financial results for the quarter ended March 31, 2024, as well as key recent clinical and corporate developments.


Clinical and Corporate Developments...

Related Keywords

Baltimore ,Maryland ,United States ,Virginia ,Vienna ,Wien ,Austria ,American ,Geert Kersten ,Securities Exchange ,European Union ,Drug Administration ,Exchange Commission ,European Medicines Agency Paediatric Committee ,Corporate Developments ,Registration Study ,European Medicines Agency ,Paediatric Committee ,Leukocyte Interleukin ,Orphan Drug ,Securities Act ,Securities Exchange Act ,